Overexpression of human C-reactive protein exacerbatesleft ventricular remodeling in diabetic cardiomyopathy

Yoshinori Mano, Toshihisa Anzai, Hidehiro Kaneko, Yuji Nagatomo, Toshiyuki Nagai, Atsushi Anzai, Yuichiro Maekawa, Toshiyuki Takahashi, Tomomi Meguro, Tsutomu Yoshikawa, Keiichi Fukuda

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: C-reactive protein (CRP) is known to be a pathogenic agent in the cardiovascular system. However,the effect of CRP on heart failure has not been elucidated. The effect of human CRP on cardiac dysfunctioninduced by diabetes mellitus (DM) using human CRP-overexpressing transgenic mice (CRP-Tg) wasexamined.Methods and Results: DM was induced in male wild-type mice (Wt/DM) and CRP-Tg (CRP/DM) by an injectionof streptozotocin. Non-diabetic wild-type mice (Wt/Con) and CRP-Tg (CRP/Con) served as controls. Echocardiographyand hemodynamic measurements 6 weeks after injection showed lower fractional shortening and leftventricular (LV) dP/dt max in CRP/DM compared with Wt/DM. Myocardial mRNA levels of interleukin-6, tumornecrosis factor-α, plasminogen activator inhibitor-1, angiotensin type 1 receptor, angiotensinogen, NADPH oxidasesubunits (p47 phox, gp91 phox), glutathione peroxidase-3. and connective tissue growth factor were increased inCRP/DM compared with Wt/DM. Nuclear staining of 8-hydroxydeoxyguanosine was also increased in CRP/DMcompared with Wt/DM. CRP/DM was associated with increased terminal deoxynucleotidyl transferase-mediateddUTP nick end-labeling positive cells and a higher ratio of Bax/Bcl-2 proteins compared with Wt/DM. The extentof cardiac fibrosis assessed by Sirius red staining and immunohistochemical staining for collagen type 1 was significantlyincreased in CRP/DM compared with Wt/DM.Conclusions: Overexpression of human CRP exacerbates LV dysfunction and remodeling in diabetic cardiomyopathy,possibly through enhancement of the inflammation, renin-angiotensin system, and oxidative stress.

Original languageEnglish
Pages (from-to)1717-1727
Number of pages11
JournalCirculation Journal
Volume75
Issue number7
DOIs
Publication statusPublished - 2011 Jul

Fingerprint

Diabetic Cardiomyopathies
Ventricular Remodeling
C-Reactive Protein
Diabetes Mellitus
Staining and Labeling
Protein C
Connective Tissue Growth Factor
Angiotensinogen
Angiotensin Type 1 Receptor
DNA Nucleotidylexotransferase
Plasminogen Activator Inhibitor 1
Renin-Angiotensin System
Streptozocin
Glutathione Peroxidase
Cardiovascular System
Collagen Type I
NADP

Keywords

  • C-reactive protein
  • Diabetes mellitus
  • Heart failure
  • Inflammation
  • Oxidative stress

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Overexpression of human C-reactive protein exacerbatesleft ventricular remodeling in diabetic cardiomyopathy. / Mano, Yoshinori; Anzai, Toshihisa; Kaneko, Hidehiro; Nagatomo, Yuji; Nagai, Toshiyuki; Anzai, Atsushi; Maekawa, Yuichiro; Takahashi, Toshiyuki; Meguro, Tomomi; Yoshikawa, Tsutomu; Fukuda, Keiichi.

In: Circulation Journal, Vol. 75, No. 7, 07.2011, p. 1717-1727.

Research output: Contribution to journalArticle

Mano, Y, Anzai, T, Kaneko, H, Nagatomo, Y, Nagai, T, Anzai, A, Maekawa, Y, Takahashi, T, Meguro, T, Yoshikawa, T & Fukuda, K 2011, 'Overexpression of human C-reactive protein exacerbatesleft ventricular remodeling in diabetic cardiomyopathy', Circulation Journal, vol. 75, no. 7, pp. 1717-1727. https://doi.org/10.1253/circj.CJ-10-1199
Mano, Yoshinori ; Anzai, Toshihisa ; Kaneko, Hidehiro ; Nagatomo, Yuji ; Nagai, Toshiyuki ; Anzai, Atsushi ; Maekawa, Yuichiro ; Takahashi, Toshiyuki ; Meguro, Tomomi ; Yoshikawa, Tsutomu ; Fukuda, Keiichi. / Overexpression of human C-reactive protein exacerbatesleft ventricular remodeling in diabetic cardiomyopathy. In: Circulation Journal. 2011 ; Vol. 75, No. 7. pp. 1717-1727.
@article{3f5d6048474f447b89317e766c9f1be2,
title = "Overexpression of human C-reactive protein exacerbatesleft ventricular remodeling in diabetic cardiomyopathy",
abstract = "Background: C-reactive protein (CRP) is known to be a pathogenic agent in the cardiovascular system. However,the effect of CRP on heart failure has not been elucidated. The effect of human CRP on cardiac dysfunctioninduced by diabetes mellitus (DM) using human CRP-overexpressing transgenic mice (CRP-Tg) wasexamined.Methods and Results: DM was induced in male wild-type mice (Wt/DM) and CRP-Tg (CRP/DM) by an injectionof streptozotocin. Non-diabetic wild-type mice (Wt/Con) and CRP-Tg (CRP/Con) served as controls. Echocardiographyand hemodynamic measurements 6 weeks after injection showed lower fractional shortening and leftventricular (LV) dP/dt max in CRP/DM compared with Wt/DM. Myocardial mRNA levels of interleukin-6, tumornecrosis factor-α, plasminogen activator inhibitor-1, angiotensin type 1 receptor, angiotensinogen, NADPH oxidasesubunits (p47 phox, gp91 phox), glutathione peroxidase-3. and connective tissue growth factor were increased inCRP/DM compared with Wt/DM. Nuclear staining of 8-hydroxydeoxyguanosine was also increased in CRP/DMcompared with Wt/DM. CRP/DM was associated with increased terminal deoxynucleotidyl transferase-mediateddUTP nick end-labeling positive cells and a higher ratio of Bax/Bcl-2 proteins compared with Wt/DM. The extentof cardiac fibrosis assessed by Sirius red staining and immunohistochemical staining for collagen type 1 was significantlyincreased in CRP/DM compared with Wt/DM.Conclusions: Overexpression of human CRP exacerbates LV dysfunction and remodeling in diabetic cardiomyopathy,possibly through enhancement of the inflammation, renin-angiotensin system, and oxidative stress.",
keywords = "C-reactive protein, Diabetes mellitus, Heart failure, Inflammation, Oxidative stress",
author = "Yoshinori Mano and Toshihisa Anzai and Hidehiro Kaneko and Yuji Nagatomo and Toshiyuki Nagai and Atsushi Anzai and Yuichiro Maekawa and Toshiyuki Takahashi and Tomomi Meguro and Tsutomu Yoshikawa and Keiichi Fukuda",
year = "2011",
month = "7",
doi = "10.1253/circj.CJ-10-1199",
language = "English",
volume = "75",
pages = "1717--1727",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "7",

}

TY - JOUR

T1 - Overexpression of human C-reactive protein exacerbatesleft ventricular remodeling in diabetic cardiomyopathy

AU - Mano, Yoshinori

AU - Anzai, Toshihisa

AU - Kaneko, Hidehiro

AU - Nagatomo, Yuji

AU - Nagai, Toshiyuki

AU - Anzai, Atsushi

AU - Maekawa, Yuichiro

AU - Takahashi, Toshiyuki

AU - Meguro, Tomomi

AU - Yoshikawa, Tsutomu

AU - Fukuda, Keiichi

PY - 2011/7

Y1 - 2011/7

N2 - Background: C-reactive protein (CRP) is known to be a pathogenic agent in the cardiovascular system. However,the effect of CRP on heart failure has not been elucidated. The effect of human CRP on cardiac dysfunctioninduced by diabetes mellitus (DM) using human CRP-overexpressing transgenic mice (CRP-Tg) wasexamined.Methods and Results: DM was induced in male wild-type mice (Wt/DM) and CRP-Tg (CRP/DM) by an injectionof streptozotocin. Non-diabetic wild-type mice (Wt/Con) and CRP-Tg (CRP/Con) served as controls. Echocardiographyand hemodynamic measurements 6 weeks after injection showed lower fractional shortening and leftventricular (LV) dP/dt max in CRP/DM compared with Wt/DM. Myocardial mRNA levels of interleukin-6, tumornecrosis factor-α, plasminogen activator inhibitor-1, angiotensin type 1 receptor, angiotensinogen, NADPH oxidasesubunits (p47 phox, gp91 phox), glutathione peroxidase-3. and connective tissue growth factor were increased inCRP/DM compared with Wt/DM. Nuclear staining of 8-hydroxydeoxyguanosine was also increased in CRP/DMcompared with Wt/DM. CRP/DM was associated with increased terminal deoxynucleotidyl transferase-mediateddUTP nick end-labeling positive cells and a higher ratio of Bax/Bcl-2 proteins compared with Wt/DM. The extentof cardiac fibrosis assessed by Sirius red staining and immunohistochemical staining for collagen type 1 was significantlyincreased in CRP/DM compared with Wt/DM.Conclusions: Overexpression of human CRP exacerbates LV dysfunction and remodeling in diabetic cardiomyopathy,possibly through enhancement of the inflammation, renin-angiotensin system, and oxidative stress.

AB - Background: C-reactive protein (CRP) is known to be a pathogenic agent in the cardiovascular system. However,the effect of CRP on heart failure has not been elucidated. The effect of human CRP on cardiac dysfunctioninduced by diabetes mellitus (DM) using human CRP-overexpressing transgenic mice (CRP-Tg) wasexamined.Methods and Results: DM was induced in male wild-type mice (Wt/DM) and CRP-Tg (CRP/DM) by an injectionof streptozotocin. Non-diabetic wild-type mice (Wt/Con) and CRP-Tg (CRP/Con) served as controls. Echocardiographyand hemodynamic measurements 6 weeks after injection showed lower fractional shortening and leftventricular (LV) dP/dt max in CRP/DM compared with Wt/DM. Myocardial mRNA levels of interleukin-6, tumornecrosis factor-α, plasminogen activator inhibitor-1, angiotensin type 1 receptor, angiotensinogen, NADPH oxidasesubunits (p47 phox, gp91 phox), glutathione peroxidase-3. and connective tissue growth factor were increased inCRP/DM compared with Wt/DM. Nuclear staining of 8-hydroxydeoxyguanosine was also increased in CRP/DMcompared with Wt/DM. CRP/DM was associated with increased terminal deoxynucleotidyl transferase-mediateddUTP nick end-labeling positive cells and a higher ratio of Bax/Bcl-2 proteins compared with Wt/DM. The extentof cardiac fibrosis assessed by Sirius red staining and immunohistochemical staining for collagen type 1 was significantlyincreased in CRP/DM compared with Wt/DM.Conclusions: Overexpression of human CRP exacerbates LV dysfunction and remodeling in diabetic cardiomyopathy,possibly through enhancement of the inflammation, renin-angiotensin system, and oxidative stress.

KW - C-reactive protein

KW - Diabetes mellitus

KW - Heart failure

KW - Inflammation

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=79959709996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959709996&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-10-1199

DO - 10.1253/circj.CJ-10-1199

M3 - Article

C2 - 21519150

AN - SCOPUS:79959709996

VL - 75

SP - 1717

EP - 1727

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 7

ER -